A Study of the Safety and Effectiveness of Levofloxacin Compared With Imipenem/Cilastatin in Patients With Pneumonia Acquired During Hospitalization
PHASE3CompletedINTERVENTIONAL
Enrollment
438
Participants
Timeline
Start Date
December 31, 1997
Study Completion Date
June 30, 2001
Conditions
Nosocomial Pneumonia
Interventions
DRUG
levofloxacin; imipenem/cilastitin
All Listed Sponsors
collaborator
PriCara, Unit of Ortho-McNeil, Inc.
INDUSTRY
lead
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
INDUSTRY
NCT00236834 - A Study of the Safety and Effectiveness of Levofloxacin Compared With Imipenem/Cilastatin in Patients With Pneumonia Acquired During Hospitalization | Biotech Hunter | Biotech Hunter